BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2014
View Archived Issues
Scientists report on new method to generate engraftable hematopoietic stem cells
Read More
Pre-mRNA splice modifiers correct motor defects in spinal muscular atrophy
Read More
NIDA awards grant to support completion of phase IIa trial of ibudilast in opioid dependence
Read More
EMA approves pediatric investigation plan for TiGenix's Cx-601
Read More
First animal model of CLN7 disease described
Read More
Immunomedics patents new anti-histone H4 MAbs
Read More
Novel polypeptides patented by Circadian Technologies
Read More
Novel anti-HER2 antibodies divulged by LFB SA
Read More
CB2 agonists show potential for the treatment of kidney disease
Read More
Critical Outcome Technologies and MD Anderson Cancer Center sign letter of intent for COTI-2
Read More
Mast Therapeutics reports topline data from phase II study of AIR-001
Read More
Alferon and Ampligen to be tested against the Ebola virus
Read More
KemPharm begins human abuse liability and gastrointestinal motility trials of KP-201
Read More
Clinical data presented for ONO-6950 at the ERS meeting
Read More
Cirmtuzumab begins phase I testing for chronic lymphocytic leukemia
Read More
RoActemra receives E.U. approval for patients with early rheumatoid arthritis
Read More
OnCore Biopharma licenses cyclophilin inhibitors for HBV infection from NeuroVive
Read More
FDA approves IND application for MT-3724
Read More
Janssen and Johnson & Johnson form research collaboration with the University of Toronto
Read More
FDA approves two new indications for Epaned
Read More
VXc-486 and its prodrug as novel promising antibacterial candidates
Read More
Once-weekly Bydureon Pen launched in U.S. for adults with type 2 diabetes
Read More
Tesaro submits rolapitant NDA to FDA
Read More